Compare GLP-1 Medications

Foundayo and Wegovy are both GLP-1 medications approved for weight loss, but they work differently, cost differently, and fit different lifestyles. Foundayo (orforglipron) is Eli Lilly's new daily pill — no food restrictions, no injections. Wegovy (semaglutide) is available as a weekly injection or daily pill (with fasting requirements). Here's how they compare on everything that matters.

Foundayo and Zepbound are both Eli Lilly products, but they serve different purposes in your weight loss journey. Lilly has explicitly positioned them as complementary: 'Use Zepbound to lose, switch to Foundayo to maintain.' But is that the right strategy for everyone? Let's compare.

Ozempic has been the dominant GLP-1 for years. Now Foundayo enters as a cheaper, oral alternative. Ozempic is FDA-approved for diabetes (widely used off-label for weight loss), while Foundayo is approved specifically for weight management. Here's the full comparison.

Both Foundayo and Rybelsus are oral GLP-1 medications, but the comparison is almost unfair. Foundayo is a newer, more convenient pill with no food restrictions. Rybelsus was the first oral GLP-1 (2019) but has strict fasting requirements and is approved for diabetes, not weight loss. Here's how they stack up.